-
1
-
-
34250020201
-
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
-
El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132:2557-2576
-
(2007)
Gastroenterology
, vol.132
, pp. 2557-2576
-
-
El-Serag, H.B.1
Rudolph, K.L.2
-
2
-
-
14944385553
-
Global cancer statistics, 2002
-
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108
-
(2005)
CA Cancer J Clin
, vol.55
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
3
-
-
7044231396
-
Hepatocellular carcinoma: Recent trends in the United States
-
El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127(5 suppl):S27-S34
-
(2004)
Gastroenterology
, vol.127
, Issue.5
, pp. S27-S34
-
-
El-Serag, H.B.1
-
4
-
-
33751210578
-
Interventional treatments for hepatocellular carcinoma
-
Guan YS, Liu Y. Interventional treatments for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2006; 5:495-500
-
(2006)
Hepatobiliary Pancreat Dis Int
, vol.5
, pp. 495-500
-
-
Guan, Y.S.1
Liu, Y.2
-
5
-
-
33847702042
-
Liver resection and transplantation in the management of hepatocellular carcinoma: A review
-
Kassahun WT, Fangmann J, Harms J, Hauss J, Bartels M. Liver resection and transplantation in the management of hepatocellular carcinoma: a review. Exp Clin Transplant 2006; 4:549-558
-
(2006)
Exp Clin Transplant
, vol.4
, pp. 549-558
-
-
Kassahun, W.T.1
Fangmann, J.2
Harms, J.3
Hauss, J.4
Bartels, M.5
-
6
-
-
28844480321
-
Management of hepatocellular carcinoma
-
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236
-
(2005)
Hepatology
, vol.42
, pp. 1208-1236
-
-
Bruix, J.1
Sherman, M.2
-
7
-
-
84864438332
-
Chemoembolization for hepatocellular carcinoma
-
Lencioni R. Chemoembolization for hepatocellular carcinoma. Semin Oncol 2012; 39:503-509
-
(2012)
Semin Oncol
, vol.39
, pp. 503-509
-
-
Lencioni, R.1
-
8
-
-
3843117688
-
The role of tumor ablation in bridging patients to liver transplantation
-
Johnson EW, Holck PS, Levy AE, Yeh MM, Yeung RS. The role of tumor ablation in bridging patients to liver transplantation. Arch Surg 2004; 139:825-830
-
(2004)
Arch Surg
, vol.139
, pp. 825-830
-
-
Johnson, E.W.1
Holck, P.S.2
Levy, A.E.3
Yeh, M.M.4
Yeung, R.S.5
-
9
-
-
0038173318
-
Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome
-
Graziadei IW, Sandmueller H, Waldenberger P, et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003; 9:557-563
-
(2003)
Liver Transpl
, vol.9
, pp. 557-563
-
-
Graziadei, I.W.1
Sandmueller, H.2
Waldenberger, P.3
-
10
-
-
2442489095
-
Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation
-
Hayashi PH, Ludkowski M, Forman LM, et al. Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transplant 2004; 4:782-787
-
(2004)
Am J Transplant
, vol.4
, pp. 782-787
-
-
Hayashi, P.H.1
Ludkowski, M.2
Forman, L.M.3
-
11
-
-
0037129704
-
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial
-
Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359:1734-1739
-
(2002)
Lancet
, vol.359
, pp. 1734-1739
-
-
Llovet, J.M.1
Real, M.I.2
Montana, X.3
-
12
-
-
0036237822
-
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
-
Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35:1164-1171
-
(2002)
Hepatology
, vol.35
, pp. 1164-1171
-
-
Lo, C.M.1
Ngan, H.2
Tso, W.K.3
-
13
-
-
84862496492
-
Advancedstage hepatocellular carcinoma: Transarterial chemoembolization versus sorafenib
-
Pinter M, Hucke F, Graziadei I, et al. Advancedstage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib. Radiology 2012; 263:590-599
-
(2012)
Radiology
, vol.263
, pp. 590-599
-
-
Pinter, M.1
Hucke, F.2
Graziadei, I.3
-
14
-
-
77949264899
-
Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: Results of the PRECISION v study
-
Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 2010; 33:41-52
-
(2010)
Cardiovasc Intervent Radiol
, vol.33
, pp. 41-52
-
-
Lammer, J.1
Malagari, K.2
Vogl, T.3
-
15
-
-
41049116317
-
Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: Results of an open-label study of 62 patients
-
Malagari K, Chatzimichael K, Alexopoulou E, et al. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Intervent Radiol 2008; 31:269-280
-
(2008)
Cardiovasc Intervent Radiol
, vol.31
, pp. 269-280
-
-
Malagari, K.1
Chatzimichael, K.2
Alexopoulou, E.3
-
16
-
-
77950810261
-
Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocellular carcinoma (HCC)
-
Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocellular carcinoma (HCC). J Surg Oncol 2010; 101:476-480
-
(2010)
J Surg Oncol
, vol.101
, pp. 476-480
-
-
Dhanasekaran, R.1
Kooby, D.A.2
Staley, C.A.3
Kauh, J.S.4
Khanna, V.5
Kim, H.S.6
-
17
-
-
84867579825
-
Transcatheter treatment of hepatocellular carcinoma with doxorubicin-loaded DC Bead (DEBDOX): Technical recommendations
-
Lencioni R, de Baere T, Burrel M, et al. Transcatheter treatment of hepatocellular carcinoma with doxorubicin-loaded DC Bead (DEBDOX): technical recommendations. Cardiovasc Intervent Radiol 2012; 35:980-985
-
(2012)
Cardiovasc Intervent Radiol
, vol.35
, pp. 980-985
-
-
Lencioni, R.1
De Baere, T.2
Burrel, M.3
-
18
-
-
84874784518
-
Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: Comparison of small-versus medium-size particles
-
Padia SA, Shivaram G, Bastawrous S, et al. Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles. J Vasc Interv Radiol 2013; 24:301-306
-
(2013)
J Vasc Interv Radiol
, vol.24
, pp. 301-306
-
-
Padia, S.A.1
Shivaram, G.2
Bastawrous, S.3
-
20
-
-
0020534533
-
Hepatic artery embolization in 120 patients with unresectable hepatoma
-
Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148: 397-401
-
(1983)
Radiology
, vol.148
, pp. 397-401
-
-
Yamada, R.1
Sato, M.2
Kawabata, M.3
Nakatsuka, H.4
Nakamura, K.5
Takashima, S.6
-
21
-
-
0036085956
-
Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials
-
Camma C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002; 224:47-54
-
(2002)
Radiology
, vol.224
, pp. 47-54
-
-
Camma, C.1
Schepis, F.2
Orlando, A.3
-
22
-
-
77953560673
-
Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: A preliminary study
-
Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study. HPB (Oxford) 2010; 12:174-180
-
(2010)
HPB (Oxford)
, vol.12
, pp. 174-180
-
-
Dhanasekaran, R.1
Kooby, D.A.2
Staley, C.A.3
Kauh, J.S.4
Khanna, V.5
Kim, H.S.6
-
23
-
-
84874775503
-
Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma
-
Prajapati HJ, Dhanasekaran R, El-Rayes BF, et al. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma. J Vasc Interv Radiol 2013; 24:307-315
-
(2013)
J Vasc Interv Radiol
, vol.24
, pp. 307-315
-
-
Prajapati, H.J.1
Dhanasekaran, R.2
El-Rayes, B.F.3
-
24
-
-
84866707150
-
Safety and feasibility of sameday discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization
-
Prajapati HJ, Rafi S, El-Rayes BF, Kauh JS, Kooby DA, Kim HS. Safety and feasibility of sameday discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization. J Vasc Interv Radiol 2012; 23:1286-1293
-
(2012)
J Vasc Interv Radiol
, vol.23
, pp. 1286-1293
-
-
Prajapati, H.J.1
Rafi, S.2
El-Rayes, B.F.3
Kauh, J.S.4
Kooby, D.A.5
Kim, H.S.6
-
25
-
-
80054925991
-
Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma
-
Sacco R, Bargellini I, Bertini M, et al. Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol 2011; 22:1545-1552
-
(2011)
J Vasc Interv Radiol
, vol.22
, pp. 1545-1552
-
-
Sacco, R.1
Bargellini, I.2
Bertini, M.3
-
26
-
-
84861192547
-
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using drug eluting beads: Implications for clinical practice and trial design
-
Burrel M, Reig M, Forner A, et al. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using drug eluting beads: implications for clinical practice and trial design. J Hepatol 2012; 56:1330-1335
-
(2012)
J Hepatol
, vol.56
, pp. 1330-1335
-
-
Burrel, M.1
Reig, M.2
Forner, A.3
-
27
-
-
79959517589
-
Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma
-
Ferrer Puchol MD, la Parra C, Esteban E, et al. Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma. Radiologia 2011; 53:246-253
-
(2011)
Radiologia
, vol.53
, pp. 246-253
-
-
Ferrer Puchol, M.D.1
La Parra, C.2
Esteban, E.3
-
28
-
-
84875601700
-
RECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)
-
Prajapati HJ, Spivey JR, Hanish SI, et al. RECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE). Ann Oncol 2012; 24:965-973
-
(2012)
Ann Oncol
, vol.24
, pp. 965-973
-
-
Prajapati, H.J.1
Spivey, J.R.2
Hanish, S.I.3
-
29
-
-
41949093036
-
Chemo-embolization for unresectable hepatocellular carcinoma with different sizes of embolization particles
-
Amesur NB, Zajko AB, Carr BI. Chemo-embolization for unresectable hepatocellular carcinoma with different sizes of embolization particles. Dig Dis Sci 2008; 53:1400-1404
-
(2008)
Dig Dis Sci
, vol.53
, pp. 1400-1404
-
-
Amesur, N.B.1
Zajko, A.B.2
Carr, B.I.3
-
30
-
-
44149096218
-
Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma
-
Maluccio MA, Covey AM, Porat LB, et al. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 2008; 19:862-869
-
(2008)
J Vasc Interv Radiol
, vol.19
, pp. 862-869
-
-
Maluccio, M.A.1
Covey, A.M.2
Porat, L.B.3
-
31
-
-
33747496271
-
Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization
-
Lewis AL, Taylor RR, Hall B, Gonzalez MV, Willis SL, Stratford PW. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol 2006; 17:1335-1343
-
(2006)
J Vasc Interv Radiol
, vol.17
, pp. 1335-1343
-
-
Lewis, A.L.1
Taylor, R.R.2
Hall, B.3
Gonzalez, M.V.4
Willis, S.L.5
Stratford, P.W.6
-
32
-
-
0242491490
-
Postchemoembolisation syndrome-tumour necrosis or hepatocyte injury
-
Wigmore SJ, Redhead DN, Thompson BN, et al. Postchemoembolisation syndrome-tumour necrosis or hepatocyte injury? Br J Cancer 2003; 89:1423-1427
-
(2003)
Br J Cancer
, vol.89
, pp. 1423-1427
-
-
Wigmore, S.J.1
Redhead, D.N.2
Thompson, B.N.3
-
33
-
-
36348969465
-
Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk
-
Kothary N, Weintraub JL, Susman J, Rundback JH. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk. J Vasc Interv Radiol 2007; 18:1517-1526
-
(2007)
J Vasc Interv Radiol
, vol.18
, pp. 1517-1526
-
-
Kothary, N.1
Weintraub, J.L.2
Susman, J.3
Rundback, J.H.4
|